Data:
{
"symbol": "SGMT",
"price": 10.1642,
"marketCap": 331167901,
"beta": 3.399,
"lastDividend": 0,
"range": "4.5-10.32",
"change": 0.8842,
"changePercentage": 9.52802,
"volume": 1326907.93452,
"averageVolume": 1049712,
"companyName": "Sagimet Biosciences Inc.",
"currency": "USD",
"cik": "0001400118",
"isin": "US7867001049",
"cusip": "786700104",
"exchangeFullName": "NASDAQ",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.sagimet.com",
"description": "Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company\u2019s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.",
"ceo": "David Happel",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "16",
"phone": "650-561-8600",
"address": "155 Bovet Road",
"city": "San Mateo",
"state": "CA",
"zip": "94402",
"image": "https://images.financialmodelingprep.com/symbol/SGMT.png",
"ipoDate": "2023-07-14",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "SGMT",
"name": "Sagimet Biosciences Inc.",
"price": 10.1642,
"changePercentage": 9.52802,
"change": 0.8842,
"volume": 1326907.93452,
"dayLow": 9.085,
"dayHigh": 10.32,
"yearHigh": 10.32,
"yearLow": 4.5,
"marketCap": 331167901,
"priceAvg50": 7.4311,
"priceAvg200": 6.63215,
"exchange": "NASDAQ",
"open": 9.39,
"previousClose": 9.28,
"timestamp": 1786730858,
"chart_vwap_daily": [
{
"t": "2026-07-06",
"v": 7.7696,
"c": 7.74
},
{
"t": "2026-07-07",
"v": 7.7751,
"c": 7.69
},
{
"t": "2026-07-08",
"v": 7.3094,
"c": 7.44
},
{
"t": "2026-07-09",
"v": 7.3343,
"c": 7.35
},
{
"t": "2026-07-10",
"v": 7.3042,
"c": 7.37
},
{
"t": "2026-07-13",
"v": 7.1412,
"c": 7.15
},
{
"t": "2026-07-14",
"v": 7.613,
"c": 7.755
},
{
"t": "2026-07-15",
"v": 7.8104,
"c": 7.99
},
{
"t": "2026-07-16",
"v": 7.6916,
"c": 7.65
},
{
"t": "2026-07-17",
"v": 7.7657,
"c": 7.82
},
{
"t": "2026-07-20",
"v": 7.4312,
"c": 7.16
},
{
"t": "2026-07-21",
"v": 7.0826,
"c": 7.07
},
{
"t": "2026-07-22",
"v": 7.0856,
"c": 7.05
},
{
"t": "2026-07-23",
"v": 6.9886,
"c": 7.01
},
{
"t": "2026-07-24",
"v": 7.0393,
"c": 7.07
},
{
"t": "2026-07-27",
"v": 7.435,
"c": 7.45
},
{
"t": "2026-07-28",
"v": 7.2461,
"c": 7.27
},
{
"t": "2026-07-29",
"v": 7.1012,
"c": 7.04
},
{
"t": "2026-07-30",
"v": 7.25,
"c": 7.31
},
{
"t": "2026-07-31",
"v": 7.1014,
"c": 7.11
},
{
"t": "2026-08-03",
"v": 6.8798,
"c": 7.15
},
{
"t": "2026-08-04",
"v": 7.7897,
"c": 7.99
},
{
"t": "2026-08-05",
"v": 8.4897,
"c": 8.64
},
{
"t": "2026-08-06",
"v": 8.6494,
"c": 8.74
},
{
"t": "2026-08-07",
"v": 8.8442,
"c": 9.06
},
{
"t": "2026-08-10",
"v": 9.342,
"c": 9.57
},
{
"t": "2026-08-11",
"v": 9.5961,
"c": 9.52
},
{
"t": "2026-08-12",
"v": 9.561,
"c": 9.39
},
{
"t": "2026-08-13",
"v": 9.3369,
"c": 9.28
},
{
"t": "2026-08-14",
"v": 9.7602,
"c": 10.165
}
],
"vwap_summary": {
"days": 30,
"days_above": 20,
"days_below": 10,
"pct_days_above": 67,
"position": "above",
"gap_pct": 4.15,
"streak_days": 1
}
}
Data:
{
"volume": 1326907.93452,
"avgVolume": 1049712,
"short_ratio": [
{
"symbol": "SGMT",
"file_date": "2026-08-13",
"date": "20260813",
"short_volume": 155797,
"short_exempt_volume": 0,
"total_volume": 355822,
"short_volume_ratio": 0.4379,
"signal": "Bullish"
}
],
"volume_profile": {
"poc": 7.1,
"vah": 9.23,
"val": 6.58,
"profile": [
{
"price": 6.61,
"volume": 116295
},
{
"price": 6.67,
"volume": 407361
},
{
"price": 6.73,
"volume": 335144
},
{
"price": 6.8,
"volume": 638185
},
{
"price": 6.86,
"volume": 179221
},
{
"price": 6.92,
"volume": 716622
},
{
"price": 6.98,
"volume": 475997
},
{
"price": 7.04,
"volume": 1124534
},
{
"price": 7.1,
"volume": 1509687
},
{
"price": 7.17,
"volume": 986618
},
{
"price": 7.23,
"volume": 370202
},
{
"price": 7.29,
"volume": 300622
},
{
"price": 7.35,
"volume": 272401
},
{
"price": 7.41,
"volume": 176743
},
{
"price": 7.47,
"volume": 283360
},
{
"price": 7.53,
"volume": 243644
},
{
"price": 7.6,
"volume": 151965
},
{
"price": 7.66,
"volume": 64802
},
{
"price": 7.72,
"volume": 182718
},
{
"price": 7.78,
"volume": 268097
},
{
"price": 7.84,
"volume": 241490
},
{
"price": 7.9,
"volume": 349547
},
{
"price": 7.97,
"volume": 281670
},
{
"price": 8.03,
"volume": 38867
},
{
"price": 8.09,
"volume": 52368
},
{
"price": 8.15,
"volume": 33482
},
{
"price": 8.21,
"volume": 64826
},
{
"price": 8.27,
"volume": 216301
},
{
"price": 8.34,
"volume": 88021
},
{
"price": 8.4,
"volume": 160773
},
{
"price": 8.46,
"volume": 342077
},
{
"price": 8.52,
"volume": 296842
},
{
"price": 8.58,
"volume": 614072
},
{
"price": 8.64,
"volume": 1267757
},
{
"price": 8.71,
"volume": 237112
},
{
"price": 8.77,
"volume": 226187
},
{
"price": 8.83,
"volume": 86884
},
{
"price": 8.89,
"volume": 161545
},
{
"price": 8.95,
"volume": 280975
},
{
"price": 9.01,
"volume": 134244
},
{
"price": 9.08,
"volume": 88230
},
{
"price": 9.14,
"volume": 77028
},
{
"price": 9.2,
"volume": 256351
},
{
"price": 9.26,
"volume": 811551
},
{
"price": 9.32,
"volume": 785934
},
{
"price": 9.38,
"volume": 566957
},
{
"price": 9.44,
"volume": 435627
},
{
"price": 9.51,
"volume": 705744
},
{
"price": 9.57,
"volume": 721872
},
{
"price": 9.63,
"volume": 273607
},
{
"price": 9.69,
"volume": 274475
},
{
"price": 9.75,
"volume": 243372
},
{
"price": 9.81,
"volume": 116685
},
{
"price": 9.88,
"volume": 128153
},
{
"price": 9.94,
"volume": 228581
},
{
"price": 10.0,
"volume": 298923
},
{
"price": 10.06,
"volume": 0
},
{
"price": 10.12,
"volume": 169610
},
{
"price": 10.18,
"volume": 10213
},
{
"price": 10.25,
"volume": 92803
}
],
"sessions": 20
}
}
Data:
{
"symbol": "SGMT",
"marketCap": 331167901,
"enterpriseValueTTM": 167237967,
"evToSalesTTM": 0,
"evToOperatingCashFlowTTM": -4.046558758046561,
"evToFreeCashFlowTTM": -4.046558758046561,
"evToEBITDATTM": -3.3642891835338617,
"netDebtToEBITDATTM": 3.2987807331696914,
"currentRatioTTM": 45.02454327366673,
"incomeQualityTTM": 0.877716179188173,
"grahamNumberTTM": null,
"grahamNetNetTTM": 4.3839790514584775,
"taxBurdenTTM": 1,
"interestBurdenTTM": 0.9472254637640336,
"workingCapitalTTM": 238569000,
"investedCapitalTTM": 240520000,
"returnOnAssetsTTM": -0.17871540826785104,
"operatingReturnOnAssetsTTM": -0.28357826959602356,
"returnOnTangibleAssetsTTM": -0.17871540826785104,
"returnOnEquityTTM": -0.3195864566592391,
"returnOnInvestedCapitalTTM": -0.20391716228520507,
"returnOnCapitalEmployedTTM": -0.20398355108890706,
"earningsYieldTTM": -0.08720485414796243,
"freeCashFlowYieldTTM": -0.12477658575974125,
"capexToOperatingCashFlowTTM": 0,
"capexToDepreciationTTM": 0,
"capexToRevenueTTM": 0,
"salesGeneralAndAdministrativeToRevenueTTM": 0,
"researchAndDevelopementToRevenueTTM": 0,
"stockBasedCompensationToRevenueTTM": 0,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 0,
"averagePayablesTTM": 1717000,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 0,
"daysOfPayablesOutstandingTTM": 0,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 0,
"cashConversionCycleTTM": 0,
"freeCashFlowToEquityTTM": -41322000,
"freeCashFlowToFirmTTM": -41322000,
"tangibleAssetValueTTM": 256155000,
"netCurrentAssetValueTTM": 236713000,
"grossProfitMarginTTM": 0,
"ebitMarginTTM": 0,
"ebitdaMarginTTM": 0,
"operatingProfitMarginTTM": 0,
"pretaxProfitMarginTTM": 0,
"continuousOperationsProfitMarginTTM": 0,
"netProfitMarginTTM": 0,
"bottomLineProfitMarginTTM": 0,
"receivablesTurnoverTTM": 0,
"payablesTurnoverTTM": 0,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 0,
"assetTurnoverTTM": 0,
"quickRatioTTM": 45.02454327366673,
"solvencyRatioTTM": -6.471340206185567,
"cashRatioTTM": 30.613766377560435,
"priceToEarningsRatioTTM": -7.941406249999998,
"priceToEarningsGrowthRatioTTM": -0.21135454779770926,
"forwardPriceToEarningsGrowthRatioTTM": -1.8756257151205762,
"priceToEarningsDilutedRatioTTM": -7.941406249999998,
"priceToEarningsDilutedGrowthRatioTTM": -0.21135454779770926,
"priceToBookRatioTTM": 2.107744248384767,
"priceToSalesRatioTTM": 0,
"priceToFreeCashFlowRatioTTM": -8.014954915057354,
"priceToOperatingCashFlowRatioTTM": -13.06590261712889,
"debtToAssetsRatioTTM": 0.00736438522567665,
"debtToEquityRatioTTM": 0.007573539458530967,
"debtToCapitalRatioTTM": 0.007516612100195664,
"longTermDebtToCapitalRatioTTM": 0,
"financialLeverageRatioTTM": 1.028400772969491,
"workingCapitalTurnoverRatioTTM": 0,
"operatingCashFlowRatioTTM": -7.625392138770991,
"operatingCashFlowSalesRatioTTM": 0,
"freeCashFlowOperatingCashFlowRatioTTM": 1,
"debtServiceCoverageRatioTTM": 0,
"interestCoverageRatioTTM": 0,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -21.3,
"capitalExpenditureCoverageRatioTTM": 0,
"dividendPaidAndCapexCoverageRatioTTM": 0,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0,
"netIncomePerShareTTM": -0.8863675785307197,
"interestDebtPerShareTTM": 0.036524843398321884,
"cashPerShareTTM": 4.5209472142021845,
"bookValuePerShareTTM": 4.822691371493373,
"tangibleBookValuePerShareTTM": 4.822691371493373,
"shareholdersEquityPerShareTTM": 4.822691371493373,
"operatingCashFlowPerShareTTM": -0.7779791643842562,
"capexPerShareTTM": 0,
"freeCashFlowPerShareTTM": -0.7779791643842562,
"netIncomePerEBTTTM": 1,
"ebtPerEbitTTM": 0.894527835835075,
"priceToFairValueTTM": 2.107744248384767,
"debtToMarketCapTTM": 0,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -3.364813629230212,
"dividendPerShareTTM": 0,
"revenue_history": [],
"dcf": {
"symbol": "SGMT",
"date": "2026-08-14",
"dcf": 1.0466802997547298,
"Stock Price": 9.925
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "SGMT",
"reportedCurrency": "USD",
"cik": "0001400118",
"filingDate": "2026-03-11",
"acceptedDate": "2026-03-11 07:30:55",
"fiscalYear": "2025",
"period": "FY",
"revenue": 0,
"costOfRevenue": 0,
"grossProfit": 0,
"researchAndDevelopmentExpenses": 39054000,
"generalAndAdministrativeExpenses": 17835000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 17835000,
"otherExpenses": 0,
"operatingExpenses": 56889000,
"costAndExpenses": 56889000,
"netInterestIncome": 5851000,
"interestIncome": 5851000,
"interestExpense": 0,
"depreciationAndAmortization": 0,
"ebitda": -51038000,
"ebit": -51038000,
"nonOperatingIncomeExcludingInterest": -5851000,
"operatingIncome": -56889000,
"totalOtherIncomeExpensesNet": 5851000,
"incomeBeforeTax": -51038000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -51038000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -51038000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -51038000,
"eps": -1.58,
"epsDiluted": -1.58,
"weightedAverageShsOut": 32345525,
"weightedAverageShsOutDil": 32345525
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "SGMT",
"reportedCurrency": "USD",
"cik": "0001400118",
"filingDate": "2026-03-11",
"acceptedDate": "2026-03-11 07:30:55",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 35021000,
"shortTermInvestments": 78103000,
"cashAndShortTermInvestments": 113124000,
"netReceivables": 0,
"accountsReceivables": 0,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 2799000,
"otherCurrentAssets": 481000,
"totalCurrentAssets": 116404000,
"propertyPlantEquipmentNet": 78000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 0,
"totalNonCurrentAssets": 78000,
"otherAssets": 0,
"totalAssets": 116482000,
"totalPayables": 1309000,
"accountPayables": 1309000,
"otherPayables": 0,
"accruedExpenses": 3687000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 78000,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 27000,
"totalCurrentLiabilities": 5101000,
"longTermDebt": 0,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 0,
"totalNonCurrentLiabilities": 0,
"otherLiabilities": 0,
"capitalLeaseObligations": 78000,
"totalLiabilities": 5101000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 3000,
"retainedEarnings": -346349000,
"additionalPaidInCapital": 457607000,
"accumulatedOtherComprehensiveIncomeLoss": 120000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 111381000,
"totalEquity": 111381000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 116482000,
"totalInvestments": 78103000,
"totalDebt": 78000,
"netDebt": -34943000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "SGMT",
"reportedCurrency": "USD",
"cik": "0001400118",
"filingDate": "2026-03-11",
"acceptedDate": "2026-03-11 07:30:55",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -51038000,
"depreciationAndAmortization": 0,
"deferredIncomeTax": 0,
"stockBasedCompensation": 6449000,
"changeInWorkingCapital": -1053000,
"accountsReceivables": 0,
"inventory": 0,
"accountsPayables": 929000,
"otherWorkingCapital": -1982000,
"otherNonCashItems": -8000,
"netCashProvidedByOperatingActivities": -45650000,
"investmentsInPropertyPlantAndEquipment": 0,
"acquisitionsNet": 0,
"purchasesOfInvestments": -106864000,
"salesMaturitiesOfInvestments": 111420000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": 4556000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 275000,
"netCommonStockIssuance": 275000,
"commonStockIssuance": 275000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": 275000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": -40819000,
"cashAtEndOfPeriod": 35021000,
"cashAtBeginningOfPeriod": 75840000,
"operatingCashFlow": -45650000,
"capitalExpenditure": 0,
"freeCashFlow": -45650000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 10.08,
"rsi": 75.13875937289282,
"sma20": 8.048,
"sma50": 7.495600000000001,
"sma200": 6.63965,
"adx": 28.376181751351066,
"atr": 0.64,
"atr_pct": 6.35,
"high_52w": 18.42,
"low_52w": 1.9,
"structure": {
"ema8": 9.201119609001603,
"ema21": 8.410114841136345,
"ema50": 7.753498814468933,
"ema200": 6.853141556267397,
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": 19.9,
"macd": {
"macd": 0.635,
"signal": 0.419,
"histogram": 0.217
},
"bollinger": {
"mid": 8.05,
"upper": 10.18,
"lower": 5.91,
"width_pct": 53.04
},
"crossover": {
"fresh_cross": false,
"pre_compressed": false,
"held_above_21": true,
"candles_since": 8,
"intraday_support": false
},
"momentum": {
"roc10": 41.8,
"checks": {
"roc_over_5": true,
"rsi_in_band": false,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 1.15,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": true,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 2.97,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": false,
"avg_vol_over_2m": false,
"mcap_over_1b": false,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 10669482.710399998,
"avg_vol": 1049712
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 1.1,
"iv_rank": 41.0
}
}
}
}
Data:
{
"prior_day": {
"high": 10.32,
"low": 9.07,
"close": 10.16,
"date": "2026-08-14"
},
"woodie_pivots": {
"PP": 9.93,
"R1": 10.79,
"S1": 9.54,
"R2": 11.18,
"S2": 8.68
},
"swing": {
"high_20d": 10.32,
"low_20d": 6.5,
"high_60d": 10.32,
"low_60d": 6.24
},
"orb": {
"high": 9.42,
"low": 9.14,
"date": "2026-08-14"
},
"vwap": 9.77,
"volume_profile": {
"poc": 7.1,
"vah": 9.23,
"val": 6.58,
"sessions": 20
},
"recent_daily": [
{
"d": "2026-07-13",
"o": 7.31,
"h": 7.31,
"l": 7.02,
"c": 7.15,
"v": 917545.200216
},
{
"d": "2026-07-14",
"o": 7.2,
"h": 7.83,
"l": 7.11,
"c": 7.755,
"v": 1168248.245415
},
{
"d": "2026-07-15",
"o": 7.76,
"h": 8.01,
"l": 7.61,
"c": 7.99,
"v": 1529983.357582
},
{
"d": "2026-07-16",
"o": 7.87,
"h": 7.945,
"l": 7.59,
"c": 7.65,
"v": 835918.50517
},
{
"d": "2026-07-17",
"o": 7.45,
"h": 8.1,
"l": 7.3357,
"c": 7.82,
"v": 1381534.185744
},
{
"d": "2026-07-20",
"o": 7.76,
"h": 8.02,
"l": 7.15,
"c": 7.16,
"v": 943024.818359
},
{
"d": "2026-07-21",
"o": 7.06,
"h": 7.22,
"l": 7,
"c": 7.07,
"v": 758693.133668
},
{
"d": "2026-07-22",
"o": 7.1,
"h": 7.2453,
"l": 7,
"c": 7.05,
"v": 780506.450379
},
{
"d": "2026-07-23",
"o": 7.025,
"h": 7.08,
"l": 6.87,
"c": 7.01,
"v": 619393.129185
},
{
"d": "2026-07-24",
"o": 7.14,
"h": 7.2,
"l": 6.86,
"c": 7.07,
"v": 910937.024579
},
{
"d": "2026-07-27",
"o": 7.12,
"h": 7.59,
"l": 7.025,
"c": 7.45,
"v": 544061.466326
},
{
"d": "2026-07-28",
"o": 7.4,
"h": 7.48,
"l": 7.1302,
"c": 7.27,
"v": 392621.046819
},
{
"d": "2026-07-29",
"o": 7.25,
"h": 7.39,
"l": 7.01,
"c": 7.04,
"v": 465041.170094
},
{
"d": "2026-07-30",
"o": 7.07,
"h": 7.35,
"l": 7,
"c": 7.31,
"v": 390202.013147
},
{
"d": "2026-07-31",
"o": 7.32,
"h": 7.33,
"l": 6.88,
"c": 7.11,
"v": 616134.26562
},
{
"d": "2026-08-03",
"o": 6.74,
"h": 7.2,
"l": 6.5,
"c": 7.15,
"v": 2991042.057902
},
{
"d": "2026-08-04",
"o": 7.15,
"h": 8,
"l": 7.15,
"c": 7.99,
"v": 1706007.125386
},
{
"d": "2026-08-05",
"o": 8,
"h": 8.74,
"l": 7.96,
"c": 8.64,
"v": 2137337.724577
},
{
"d": "2026-08-06",
"o": 8.46,
"h": 8.975,
"l": 8.29,
"c": 8.74,
"v": 1465728.211285
},
{
"d": "2026-08-07",
"o": 8.91,
"h": 9.09,
"l": 8.4501,
"c": 9.06,
"v": 1113093.245709
},
{
"d": "2026-08-10",
"o": 8.91,
"h": 9.61,
"l": 8.8,
"c": 9.57,
"v": 1799216.779304
},
{
"d": "2026-08-11",
"o": 9.57,
"h": 10.01,
"l": 9.2801,
"c": 9.52,
"v": 1480438.204326
},
{
"d": "2026-08-12",
"o": 9.55,
"h": 9.85,
"l": 9.38,
"c": 9.39,
"v": 1096390.104161
},
{
"d": "2026-08-13",
"o": 9.52,
"h": 9.67,
"l": 9.15,
"c": 9.28,
"v": 966107.181015
},
{
"d": "2026-08-14",
"o": 9.42,
"h": 10.32,
"l": 9.07,
"c": 10.165,
"v": 1326727.934518
}
]
}
Data:
{
"estimates": [
{
"symbol": "SGMT",
"date": "2030-12-31",
"revenueLow": 252458850,
"revenueHigh": 252458850,
"revenueAvg": 252458850,
"ebitdaLow": 151475310,
"ebitdaHigh": 151475310,
"ebitdaAvg": 151475310,
"ebitLow": 151475310,
"ebitHigh": 151475310,
"ebitAvg": 151475310,
"netIncomeLow": 11860780,
"netIncomeHigh": 11860780,
"netIncomeAvg": 11860780,
"sgaExpenseLow": 529229487,
"sgaExpenseHigh": 529229487,
"sgaExpenseAvg": 529229487,
"epsAvg": 0.36669,
"epsHigh": 0.36669,
"epsLow": 0.36669,
"numAnalystsRevenue": 6,
"numAnalystsEps": 5
},
{
"symbol": "SGMT",
"date": "2029-12-31",
"revenueLow": 91446337,
"revenueHigh": 91446337,
"revenueAvg": 91446337,
"ebitdaLow": 54867802,
"ebitdaHigh": 54867802,
"ebitdaAvg": 54867802,
"ebitLow": 54867802,
"ebitHigh": 54867802,
"ebitAvg": 54867802,
"netIncomeLow": -31814089,
"netIncomeHigh": -31814089,
"netIncomeAvg": -31814089,
"sgaExpenseLow": 191698956,
"sgaExpenseHigh": 191698956,
"sgaExpenseAvg": 191698956,
"epsAvg": -0.98357,
"epsHigh": -0.98357,
"epsLow": -0.98357,
"numAnalystsRevenue": 6,
"numAnalystsEps": 5
},
{
"symbol": "SGMT",
"date": "2028-12-31",
"revenueLow": 23869429,
"revenueHigh": 23869429,
"revenueAvg": 23869429,
"ebitdaLow": 14321657,
"ebitdaHigh": 14321657,
"ebitdaAvg": 14321657,
"ebitLow": 14321657,
"ebitHigh": 14321657,
"ebitAvg": 14321657,
"netIncomeLow": -92847185,
"netIncomeHigh": -27498225,
"netIncomeAvg": -60172705,
"sgaExpenseLow": 50037484,
"sgaExpenseHigh": 50037484,
"sgaExpenseAvg": 50037484,
"epsAvg": -1.53901,
"epsHigh": -0.85014,
"epsLow": -2.87048,
"numAnalystsRevenue": 8,
"numAnalystsEps": 8
},
{
"symbol": "SGMT",
"date": "2027-12-31",
"revenueLow": 7526500,
"revenueHigh": 7526500,
"revenueAvg": 7526500,
"ebitdaLow": 4515900,
"ebitdaHigh": 4515900,
"ebitdaAvg": 4515900,
"ebitLow": 4515900,
"ebitHigh": 4515900,
"ebitAvg": 4515900,
"netIncomeLow": -53668667,
"netIncomeHigh": -24831660,
"netIncomeAvg": -39250163.5,
"sgaExpenseLow": 15777801,
"sgaExpenseHigh": 15777801,
"sgaExpenseAvg": 15777801,
"epsAvg": -1.25061,
"epsHigh": -0.7677,
"epsLow": -1.65923,
"numAnalystsRevenue": 6,
"numAnalystsEps": 7
}
],
"price_target": {
"symbol": "SGMT",
"targetHigh": 8,
"targetLow": 6,
"targetConsensus": 7,
"targetMedian": 7
},
"ratings": {
"symbol": "SGMT",
"rating": "C+",
"overallScore": 2,
"discountedCashFlowScore": 3,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 4,
"priceToEarningsScore": 1,
"priceToBookScore": 3
},
"grades": [
{
"symbol": "SGMT",
"date": "2026-05-19",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "SGMT",
"date": "2026-05-04",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "SGMT",
"date": "2026-04-29",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "SGMT",
"date": "2026-03-11",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "SGMT",
"date": "2026-02-03",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "SGMT",
"date": "2025-11-14",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "SGMT",
"date": "2025-10-02",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Citizens Maintains Market Outperform on Sagimet Biosciences, Raises Price Target to $29",
"url": "https://www.benzinga.com/news/26/08/61207591/citizens-maintains-market-outperform-sagimet-biosciences-raises-price-target-29",
"source": "benzinga",
"date": "2026-08-14T13:01:17.678000+00:00",
"summary": "Citizens analyst Jonathan Wolleben maintains Sagimet Biosciences (NASDAQ:SGMT) with a Market Outperform and raises the price target from $12 to $29.",
"image": ""
},
{
"title": "Citizens raises Sagimet stock price target to $29 on acne drug By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/citizens-raises-sagimet-stock-price-target-to-29-on-acne-drug-93CH-4860052",
"source": "Investing.com",
"date": "2026-08-14T09:10:48Z",
"summary": "Investing.com - Citizens raised its price target on Sagimet Biosciences Inc (NASDAQ:SGMT) to $29.00 from $12.00 while maintaining a Market Outperform rating. The stock currently trades at $9.28, near its 52-week high of $10.01, reflecting strong momentum with an 83% gain over the",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4519D_1200_L.jpg"
},
{
"title": "FDA clears Sagimet's phase 3 trial for acne treatment denifanstat By Investing.com",
"url": "https://www.investing.com/news/company-news/fda-clears-sagimets-phase-3-trial-for-acne-treatment-denifanstat-93CH-4857367",
"source": "Investing.com",
"date": "2026-08-13T11:04:37Z",
"summary": "FOSTER CITY, Calif. - Sagimet Biosciences Inc. (NASDAQ:SGMT) announced today that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase 3 clinical trial of denifanstat in moderate to severe acne, according to a press release statem",
"image": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png"
},
{
"title": "Sagimet Biosciences director George Kemble sells $201,146 in shares By Investing.com",
"url": "https://www.investing.com/news/insider-trading-news/sagimet-biosciences-director-george-kemble-sells-201146-in-shares-93CH-4856507",
"source": "Investing.com",
"date": "2026-08-13T01:19:29Z",
"summary": "Sagimet Biosciences Inc. (NASDAQ:SGMT) Director George Kemble sold shares totaling $201,146 on August 11, 2026, according to a recent Form 4 filing with the Securities and Exchange Commission. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4416N_1200_L.jpg"
},
{
"title": "Sagimet Biosciences Receives FDA \u201cStudy May Proceed\u201d Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients",
"url": "https://www.globenewswire.com/news-release/2026/08/13/3344344/0/en/sagimet-biosciences-receives-fda-study-may-proceed-letter-and-ind-clearance-for-phase-3-trial-in-acne-in-adolescent-and-adult-patients.html",
"source": "GlobeNewsWire",
"date": "2026-08-13 07:00:00",
"summary": "Phase 3 clinical trial of denifanstat in moderate to severe acne patients in the U.S.\u00a0on track to initiate in second half of 2026 Phase 3 clinical trial of denifanstat in moderate to severe acne patients in the U.S.\u00a0on track to initiate in second half of 2026",
"image": "https://images.financialmodelingprep.com/news/sagimet-biosciences-receives-fda-study-may-proceed-letter-and-20260813.jpg"
},
{
"title": "Why is Sagimet Biosciences stock climbing today? By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/why-is-sagimet-biosciences-stock-climbing-today-93CH-4854113",
"source": "Investing.com",
"date": "2026-08-12T10:02:36Z",
"summary": "Investing.com -- Sagimet Biosciences stock rose 3.4% in pre-open trading to reach $9.84 after the company released its second-quarter 2026 financial results before the bell, reporting a net loss of $14.0 million for the quarter ended June 30 -- a figure that came in marginally ah",
"image": "https://content-media.investing.com/news/SP500StandardandPoors500Index_800x533_L_1657544297.jpg"
},
{
"title": "Sagimet Biosciences at Canaccord Genuity conference: acne pivot gains traction By Investing.com",
"url": "https://www.investing.com/news/transcripts/sagimet-biosciences-at-canaccord-genuity-conference-acne-pivot-gains-traction-93CH-4852401",
"source": "Investing.com",
"date": "2026-08-11T18:01:55Z",
"summary": "Sagimet Biosciences (SGMT) used Canaccord Genuity's 46th Annual Growth Conference on Tuesday, 11 August 2026, to outline a sharper focus on acne after its lead drug showed encouraging results in a China study. The company described a large market opportunity and a favorable safet",
"image": "https://content-media.investing.com/news/LYNXMPEDAF0IH_L.jpg"
},
{
"title": "Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference",
"url": "https://www.globenewswire.com/news-release/2026/08/04/3338136/0/en/Sagimet-Biosciences-to-Participate-in-the-Canaccord-Genuity-46th-Annual-Growth-Conference.html",
"source": "GlobeNewsWire",
"date": "2026-08-04 07:00:00",
"summary": "FOSTER CITY, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.\u00a0(Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in th",
"image": "https://images.financialmodelingprep.com/news/sagimet-biosciences-to-participate-in-the-canaccord-genuity-46th-20260804.jpg"
},
{
"title": "Sagimet Biosciences (SGMT) Attracts Attention After Russel Indexes Inclusion",
"url": "https://finance.yahoo.com/markets/stocks/articles/sagimet-biosciences-sgmt-attracts-attention-154257397.html",
"source": "Yahoo! Finance",
"date": "2026-07-15T15:42:57Z",
"summary": "Sagimet Biosciences Inc. (NASDAQ:SGMT) is one of the 10 best stocks under $10 that could triple.\n\nOn June 29, Sagimet Biosciences Inc. (NASDAQ:SGMT) announced that it had been included in the broader Russell 3000 Index and the small-cap focused Russell 2000 Index, as part of the ",
"image": "https://s.yimg.com/lo/mysterio/api/C16C8E9A44A9191B661BEDD8AE199CDB412ADEFEFF5FBBA515F1199C0F125E48/subgraphmysterio/resizefill_w1200_h802;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F382f812a97a6f4b17398b231c6857399"
},
{
"title": "Sagimet Biosciences Joins the Russell 2000\u00ae and Russell 3000\u00ae Indexes",
"url": "https://www.globenewswire.com/news-release/2026/06/29/3318815/0/en/Sagimet-Biosciences-Joins-the-Russell-2000-and-Russell-3000-Indexes.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-29T11:00:00Z",
"summary": "Sagimet Biosciences Inc. (Nasdaq: SGMT) announced its inclusion in the Russell 3000 and Russell 2000 indexes effective June 29, 2026. The clinical-stage biopharmaceutical company plans to initiate a Phase 3 clinical trial of denifanstat for moderate to severe acne in the second h",
"image": "https://ml.globenewswire.com/Resource/Download/e944daed-3f71-402b-bb23-82149e5c0d26"
},
{
"title": "Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.globenewswire.com/news-release/2026/06/23/3315683/0/en/Sagimet-Biosciences-Announces-Participation-in-Upcoming-Investor-Conference-and-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-23T00:49:00Z",
"summary": "Sagimet Biosciences announced management participation in the Leerink Partners Therapeutics Forum on July 15, 2026. The company also approved an inducement grant of 34,300 stock options to two newly hired employees as part of their employment compensation packages.",
"image": "https://ml.globenewswire.com/Resource/Download/e944daed-3f71-402b-bb23-82149e5c0d26"
},
{
"title": "Here's Why Sagimet Biosciences Inc. (SGMT) Could be Great Choice for a Bottom Fisher",
"url": "https://www.zacks.com/stock/news/2932312/here-s-why-sagimet-biosciences-inc-sgmt-could-be-great-choice-for-a-bottom-fisher?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2932312",
"source": "Zacks Investment Research",
"date": "2026-06-04 10:56:10",
"summary": "After losing some value lately, a hammer chart pattern has been formed for Sagimet Biosciences Inc. (SGMT), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near te",
"image": "https://images.financialmodelingprep.com/news/heres-why-sagimet-biosciences-inc-sgmt-could-be-great-20260604.jpg"
},
{
"title": "Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH",
"url": "https://www.globenewswire.com/news-release/2026/05/27/3301763/0/en/Sagimet-Biosciences-Presents-Two-Posters-at-EASL-2026-on-Denifanstat-Resmetirom-Combination-in-MASH.html",
"source": "GlobeNewsWire",
"date": "2026-05-27 07:00:00",
"summary": "Phase 1 clinical data poster selected as a Best of EASL 2026 presentation Combination of denifanstat and resmetirom was generally well-tolerated in Phase 1 clinical trial Phase 1 data show rapid reductions in cholesterol levels, suggesting the potential for a cardiovascular benef",
"image": "https://images.financialmodelingprep.com/news/sagimet-biosciences-presents-two-posters-at-easl-2026-on-20260527.jpg"
},
{
"title": "Wall Street Analysts Believe Sagimet Biosciences Inc. (SGMT) Could Rally 298.5%: Here's is How to Trade",
"url": "https://www.zacks.com/stock/news/2924741/wall-street-analysts-believe-sagimet-biosciences-inc-sgmt-could-rally-298-5-here-s-is-how-to-trade?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|consensus_price_target-2924741",
"source": "Zacks Investment Research",
"date": "2026-05-21 10:55:22",
"summary": "The mean of analysts' price targets for Sagimet Biosciences Inc. (SGMT) points to a 298.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the ",
"image": "https://images.financialmodelingprep.com/news/wall-street-analysts-believe-sagimet-biosciences-inc-sgmt-could-20260521.jpg"
},
{
"title": "Sagimet Biosciences: Making The Bull Case For Differentiated Denifanstat",
"url": "https://seekingalpha.com/article/4904749-sagimet-biosciences-making-the-bull-case-for-differentiated-denifanstat",
"source": "Seeking Alpha",
"date": "2026-05-14 14:19:22",
"summary": "Sagimet Biosciences receives a Buy rating, driven by denifanstat's potential in MASH and acne, despite higher risk. Denifanstat met all endpoints in Phase 2b MASH and Phase 3 China acne trials, supporting optimism for US acne Phase 3. SGMT's near-term catalysts include US Phase 3",
"image": "https://images.financialmodelingprep.com/news/sagimet-biosciences-making-the-bull-case-for-differentiated-denifanstat-20260514.jpg"
},
{
"title": "Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer",
"url": "https://www.globenewswire.com/news-release/2026/04/20/3276841/0/en/Sagimet-Biosciences-Announces-Appointment-of-Andreas-Grauer-MD-as-Chief-Medical-Officer.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-20T11:00:00Z",
"summary": "Sagimet Biosciences appointed Dr. Andreas Grauer as Chief Medical Officer effective April 20, 2026, replacing retiring Dr. Eduardo Martins who will serve as external scientific advisor. Grauer brings over two decades of biopharmaceutical leadership experience from roles at Omeros",
"image": "https://ml.globenewswire.com/Resource/Download/e944daed-3f71-402b-bb23-82149e5c0d26"
},
{
"title": "Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.globenewswire.com/news-release/2026/04/06/3268332/0/en/Sagimet-Biosciences-Announces-Poster-and-Oral-Presentations-at-the-Fueling-MASH-Metabolic-Drivers-and-Inflammatory-Crosstalk-Keystone-Symposium-and-Inducement-Grant-Under-Nasdaq-Li.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-06T11:00:00Z",
"summary": "Sagimet Biosciences announced presentations of Phase 2b FASCINATE-2 trial data on denifanstat for MASH at the Fueling MASH Keystone Symposium in Vancouver. The data shows that denifanstat-treated MASH patients who were histological responders demonstrated significant reduction in",
"image": "https://ml.globenewswire.com/Resource/Download/e944daed-3f71-402b-bb23-82149e5c0d26"
},
{
"title": "Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences",
"url": "https://www.globenewswire.com/news-release/2026/02/05/3232821/0/en/Sagimet-Biosciences-Announces-Participation-in-Two-Upcoming-Investor-Conferences.html",
"source": "GlobeNewswire Inc.",
"date": "2026-02-05T12:00:00Z",
"summary": "Sagimet Biosciences announced that management will participate in two investor conferences in February 2026: the Guggenheim Emerging Outlook Biotech Summit on February 11 and the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26. The company is developing",
"image": "https://ml.globenewswire.com/Resource/Download/e944daed-3f71-402b-bb23-82149e5c0d26"
},
{
"title": "Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference",
"url": "https://www.globenewswire.com/news-release/2025/10/24/3172712/0/en/Denifanstat-Achieved-All-Endpoints-in-the-Treatment-of-Moderate-to-Severe-Acne-in-Phase-3-Clinical-Trial-in-Acne-in-China-A-Presentation-at-the-2025-Fall-Clinical-Dermatology-Confe.html",
"source": "GlobeNewswire Inc.",
"date": "2025-10-24T11:00:00Z",
"summary": "Sagimet Biosciences reported positive Phase 3 clinical trial results for denifanstat in treating moderate to severe acne in China, with the drug meeting all primary and secondary endpoints and being well-tolerated.",
"image": "https://ml.globenewswire.com/Resource/Download/e944daed-3f71-402b-bb23-82149e5c0d26"
},
{
"title": "Positive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be Presented at the EADV Congress 2025 by Partner Ascletis",
"url": "https://www.globenewswire.com/news-release/2025/09/17/3151490/0/en/Positive-Phase-3-Results-for-Denifanstat-for-the-Treatment-of-Moderate-to-Severe-Acne-to-be-Presented-at-the-EADV-Congress-2025-by-Partner-Ascletis.html",
"source": "GlobeNewswire Inc.",
"date": "2025-09-17T11:00:00Z",
"summary": "Sagimet Biosciences reported positive Phase 3 clinical trial results for denifanstat, a novel oral medication for treating moderate to severe acne, with significant improvements in lesion reduction and treatment success rates.",
"image": "https://ml.globenewswire.com/Resource/Download/e944daed-3f71-402b-bb23-82149e5c0d26"
},
{
"title": "Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit",
"url": "https://www.globenewswire.com/news-release/2025/09/10/3147619/0/en/Sagimet-Biosciences-Announces-Upcoming-Presentations-at-9th-Annual-MASH-Drug-Development-Summit.html",
"source": "GlobeNewswire Inc.",
"date": "2025-09-10T11:00:00Z",
"summary": "Sagimet Biosciences will present two oral presentations at the 9th Annual MASH Drug Development Summit, focusing on their FASN inhibitor denifanstat and its potential treatment for metabolic dysfunction associated steatohepatitis (MASH).",
"image": "https://ml.globenewswire.com/Resource/Download/e944daed-3f71-402b-bb23-82149e5c0d26"
}
]
Data:
[
{
"symbol": "SGMT",
"date": "2026-11-12",
"epsActual": null,
"epsEstimated": -0.25,
"revenueActual": null,
"revenueEstimated": 166667,
"lastUpdated": "2026-08-14"
},
{
"symbol": "SGMT",
"date": "2026-08-11",
"epsActual": -0.26,
"epsEstimated": -0.251,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-08-14"
},
{
"symbol": "SGMT",
"date": "2026-05-12",
"epsActual": -0.33,
"epsEstimated": -0.39,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-08-12"
},
{
"symbol": "SGMT",
"date": "2026-03-11",
"epsActual": -0.29,
"epsEstimated": -0.43,
"revenueActual": null,
"revenueEstimated": 1111111,
"lastUpdated": "2026-06-11"
},
{
"symbol": "SGMT",
"date": "2025-11-13",
"epsActual": -0.4,
"epsEstimated": -0.41,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-02-11"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "SGMT",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "SGMT",
"periods": [
{
"file_period": "202603b",
"settlement_date": "20260330",
"quantity_fails": 3654,
"price": 4.89
},
{
"file_period": "202604a",
"settlement_date": "20260406",
"quantity_fails": 117,
"price": 5.32
},
{
"file_period": "202604b",
"settlement_date": "20260429",
"quantity_fails": 1102,
"price": 8.75
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 48625,
"price": 7.79
},
{
"file_period": "202607a",
"settlement_date": "20260709",
"quantity_fails": 6,
"price": 7.44
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "SGMT",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-11",
"reportingCik": "0001858176",
"companyCik": "0001400118",
"transactionType": "M-Exempt",
"securitiesOwned": 358073,
"reportingName": "Kemble George",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 9751,
"price": 6.36,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/0001193125-26-347407-index.htm"
},
{
"symbol": "SGMT",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-11",
"reportingCik": "0001858176",
"companyCik": "0001400118",
"transactionType": "M-Exempt",
"securitiesOwned": 82367,
"reportingName": "Kemble George",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 10455,
"price": 6.36,
"securityName": "Series A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/0001193125-26-347407-index.htm"
},
{
"symbol": "SGMT",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-11",
"reportingCik": "0001858176",
"companyCik": "0001400118",
"transactionType": "M-Exempt",
"securitiesOwned": 71912,
"reportingName": "Kemble George",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 9751,
"price": 6.36,
"securityName": "Series A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/0001193125-26-347407-index.htm"
},
{
"symbol": "SGMT",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-11",
"reportingCik": "0001858176",
"companyCik": "0001400118",
"transactionType": "S-Sale",
"securitiesOwned": 62161,
"reportingName": "Kemble George",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 20206,
"price": 9.9548,
"securityName": "Series A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/0001193125-26-347407-index.htm"
},
{
"symbol": "SGMT",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-11",
"reportingCik": "0001858176",
"companyCik": "0001400118",
"transactionType": "M-Exempt",
"securitiesOwned": 35977,
"reportingName": "Kemble George",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 10455,
"price": 6.36,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1400118/000119312526347407/0001193125-26-347407-index.htm"
},
{
"symbol": "SGMT",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0001623567",
"companyCik": "0001400118",
"transactionType": "S-Sale",
"securitiesOwned": 741570,
"reportingName": "Happel David",
"typeOfOwner": "director, officer: President & CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 64051,
"price": 7.7605,
"securityName": "Series A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1400118/000119312526312397/0001193125-26-312397-index.htm"
},
{
"symbol": "SGMT",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0001975022",
"companyCik": "0001400118",
"transactionType": "S-Sale",
"securitiesOwned": 224414,
"reportingName": "Rozek Elizabeth",
"typeOfOwner": "officer: Chief Legal & Admin. Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 10545,
"price": 7.7603,
"securityName": "Series A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1400118/000119312526312394/0001193125-26-312394-index.htm"
},
{
"symbol": "SGMT",
"filingDate": "2026-07-22",
"transactionDate": "2026-07-20",
"reportingCik": "0001858176",
"companyCik": "0001400118",
"transactionType": "S-Sale",
"securitiesOwned": 62161,
"reportingName": "Kemble George",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 18844,
"price": 7.4575,
"securityName": "Series A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1400118/000119312526312386/0001193125-26-312386-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "SGMT",
"executed_at": "2026-08-14T18:02:29.462000Z",
"size": 2000.0,
"price": 10.1691,
"premium": 20338.2,
"volume": 2000.0,
"trade_code": " "
},
{
"ticker": "SGMT",
"executed_at": "2026-08-14T18:06:07.757000Z",
"size": 1500.0,
"price": 10.16,
"premium": 15240.0,
"volume": 1500.0,
"trade_code": " "
},
{
"ticker": "SGMT",
"executed_at": "2026-08-14T18:06:10.038000Z",
"size": 900.0,
"price": 10.1664,
"premium": 9149.76,
"volume": 900.0,
"trade_code": " "
},
{
"ticker": "SGMT",
"executed_at": "2026-08-14T18:06:38.312000Z",
"size": 718.0,
"price": 10.16,
"premium": 7294.88,
"volume": 718.0,
"trade_code": "F"
},
{
"ticker": "SGMT",
"executed_at": "2026-08-14T18:03:23.597000Z",
"size": 422.0,
"price": 10.175,
"premium": 4293.85,
"volume": 422.0,
"trade_code": " "
},
{
"ticker": "SGMT",
"executed_at": "2026-08-14T18:06:38.312000Z",
"size": 382.0,
"price": 10.16,
"premium": 3881.12,
"volume": 382.0,
"trade_code": "F"
},
{
"ticker": "SGMT",
"executed_at": "2026-08-14T18:06:10.221000Z",
"size": 300.0,
"price": 10.16,
"premium": 3048.0,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "SGMT",
"executed_at": "2026-08-14T18:01:19.075000Z",
"size": 300.0,
"price": 10.175,
"premium": 3052.5,
"volume": 300.0,
"trade_code": " "
}
],
"ats": {
"symbol": "SGMT",
"date": "20260813",
"ats_volume": 0,
"total_volume": 355822,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260813",
"ats_ratio": 0.0
},
{
"date": "20260812",
"ats_ratio": 0.0
},
{
"date": "20260811",
"ats_ratio": 0.0
},
{
"date": "20260810",
"ats_ratio": 0.0
},
{
"date": "20260807",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "SGMT",
"days": [
{
"date": "2026-08-14",
"close": 10.165,
"vwap": 9.76,
"volume": 1326727,
"vwap_discount_pct": -3.98
},
{
"date": "2026-08-13",
"close": 9.28,
"vwap": 9.34,
"volume": 966107,
"vwap_discount_pct": 0.61
},
{
"date": "2026-08-12",
"close": 9.39,
"vwap": 9.56,
"volume": 1096390,
"vwap_discount_pct": 1.82
},
{
"date": "2026-08-11",
"close": 9.52,
"vwap": 9.6,
"volume": 1480438,
"vwap_discount_pct": 0.8
},
{
"date": "2026-08-10",
"close": 9.57,
"vwap": 9.34,
"volume": 1799216,
"vwap_discount_pct": -2.38
}
],
"avg_vwap_discount_pct": -0.63,
"signal": "Distribution"
},
"options_flow": [],
"net_premium": {
"ticker": "SGMT",
"net_call_premium": "17005.00",
"net_put_premium": "-6159.00",
"call_premium": "45552.00",
"put_premium": "11883.00",
"bullish_premium": "36742.00",
"bearish_premium": "13578.00",
"put_call_ratio": "0.75675675675675675676",
"iv_rank": "40.6301",
"implied_move_perc": "0.158000",
"gex_ratio": "0.53407154410793042309",
"gex_net_change": "8214.7070",
"gex_call": "77314.3416",
"gex_put": "-41291.3898",
"gex_net": 36022.9518,
"gex_call_delta": "506146.1030",
"gex_put_delta": "-147552.4034",
"gex_date": "2026-08-14"
},
"hot_chains": [
{
"underlying_symbol": "SGMT",
"expires": "2026-08-21",
"open_interest": 2,
"option_type": "put",
"delta": -0.427225125179536,
"ask_volume": 2,
"last_price": "0.47",
"implied_volatility": "0.980298174225552",
"gamma": 0.2761859488536,
"avg_price": "0.4516336633663366336633663367",
"bid_volume": 200,
"nbbo_ask": "0.50",
"strike": "10",
"option_symbol": "SGMT260821P00010000",
"total_premium": "9123.00",
"iv": 1.003836165603144,
"volume": 202,
"nbbo_bid": "0.20"
},
{
"underlying_symbol": "SGMT",
"expires": "2028-01-21",
"open_interest": 65,
"option_type": "call",
"delta": 0.523423408166309,
"ask_volume": 65,
"last_price": "2.50",
"implied_volatility": "0.855301104299135",
"gamma": 0.0355305770163581,
"avg_price": "2.3795454545454545454545454545",
"bid_volume": 20,
"nbbo_ask": "3.00",
"strike": "17.5",
"option_symbol": "SGMT280121C00017500",
"total_premium": "26175.00",
"iv": 0.91977472386587,
"volume": 110,
"nbbo_bid": "2.35"
},
{
"underlying_symbol": "SGMT",
"expires": "2026-10-16",
"open_interest": 2106,
"option_type": "call",
"delta": 0.583427741695933,
"ask_volume": 30,
"last_price": "1.50",
"implied_volatility": "0.838839600796366",
"gamma": 0.1188701062518492,
"avg_price": "1.2150000000000000000000000000",
"bid_volume": 40,
"nbbo_ask": "1.50",
"strike": "10",
"option_symbol": "SGMT261016C00010000",
"total_premium": "8505.00",
"iv": 0.777158746451255,
"volume": 70,
"nbbo_bid": "1.25"
},
{
"underlying_symbol": "SGMT",
"expires": "2026-08-21",
"open_interest": 672,
"option_type": "call",
"delta": 0.573459963645297,
"ask_volume": 3,
"last_price": "0.57",
"implied_volatility": "1.0740142387576",
"gamma": 0.286537677296233,
"avg_price": "0.3339285714285714285714285714",
"bid_volume": 25,
"nbbo_ask": "0.65",
"strike": "10",
"option_symbol": "SGMT260821C00010000",
"total_premium": "935.00",
"iv": 0.967259188306749,
"volume": 28,
"nbbo_bid": "0.55"
},
{
"underlying_symbol": "SGMT",
"expires": "2026-09-18",
"open_interest": 29,
"option_type": "call",
"delta": 0.243025947880972,
"ask_volume": 0,
"last_price": "0.30",
"implied_volatility": "0.792081109698641",
"gamma": 0.1228403215011637,
"avg_price": "0.2115384615384615384615384616",
"bid_volume": 20,
"nbbo_ask": "0.35",
"strike": "12.5",
"option_symbol": "SGMT260918C00012500",
"total_premium": "550.00",
"iv": 0.807730715281073,
"volume": 26,
"nbbo_bid": "0.20"
},
{
"underlying_symbol": "SGMT",
"expires": "2027-01-15",
"open_interest": 163,
"option_type": "call",
"delta": 0.2181050396010277,
"ask_volume": 0,
"last_price": "0.50",
"implied_volatility": "0.774660919612098",
"gamma": 0.0558115792436371,
"avg_price": "0.50",
"bid_volume": 0,
"nbbo_ask": "0.60",
"strike": "17.5",
"option_symbol": "SGMT270115C00017500",
"total_premium": "1000.00",
"iv": 0.789460866950912,
"volume": 20,
"nbbo_bid": "0.40"
},
{
"underlying_symbol": "SGMT",
"expires": "2026-10-16",
"open_interest": 2015,
"option_type": "put",
"delta": -0.414253897071962,
"ask_volume": 15,
"last_price": "1.45",
"implied_volatility": "0.803999661066583",
"gamma": 0.1170565794785397,
"avg_price": "1.45",
"bid_volume": 0,
"nbbo_ask": "1.50",
"strike": "10",
"option_symbol": "SGMT261016P00010000",
"total_premium": "2175.00",
"iv": 0.787016895320742,
"volume": 15,
"nbbo_bid": "1.35"
},
{
"underlying_symbol": "SGMT",
"expires": "2027-01-15",
"open_interest": 932,
"option_type": "call",
"delta": 0.788271099063641,
"ask_volume": 10,
"last_price": "2.84",
"implied_volatility": "0.866993783733536",
"gamma": 0.0483868285526288,
"avg_price": "2.84",
"bid_volume": 0,
"nbbo_ask": "2.90",
"strike": "7.5",
"option_symbol": "SGMT270115C00007500",
"total_premium": "2840.00",
"iv": 0.910990752395836,
"volume": 10,
"nbbo_bid": "2.75"
}
],
"gamma_profile": {
"ticker": "SGMT",
"spot": 10.16,
"date": "2026-08-14",
"flip_point": 6.3,
"net_gex": 36022.95,
"call_walls": [
{
"strike": 10.0,
"gex": 51960.5
},
{
"strike": 7.5,
"gex": 15532.3
},
{
"strike": 12.5,
"gex": 3909.17
}
],
"put_walls": [
{
"strike": 10.0,
"gex": -27409.9
},
{
"strike": 5.0,
"gex": -8201.21
},
{
"strike": 7.5,
"gex": -5577.15
}
],
"by_strike": [
{
"strike": 2.5,
"call_gex": 487.02,
"put_gex": -86.7,
"net_gex": 400.32
},
{
"strike": 5.0,
"call_gex": 2604.34,
"put_gex": -8201.21,
"net_gex": -5596.87
},
{
"strike": 7.5,
"call_gex": 15532.3,
"put_gex": -5577.15,
"net_gex": 9955.15
},
{
"strike": 10.0,
"call_gex": 51960.5,
"put_gex": -27409.9,
"net_gex": 24550.61
},
{
"strike": 12.5,
"call_gex": 3909.17,
"put_gex": -9.76,
"net_gex": 3899.41
},
{
"strike": 15.0,
"call_gex": 1614.21,
"put_gex": -6.67,
"net_gex": 1607.54
},
{
"strike": 17.5,
"call_gex": 1206.8,
"put_gex": 0.0,
"net_gex": 1206.8
}
]
},
"oi_changes": {
"net_call_oi_change": 2017,
"net_put_oi_change": 2015,
"top": [
{
"strike": "10",
"oi_change": 2015,
"type": "put"
},
{
"strike": "10",
"oi_change": 1970,
"type": "call"
},
{
"strike": "10",
"oi_change": 45,
"type": "call"
},
{
"strike": "10",
"oi_change": 2,
"type": "call"
},
{
"strike": "5",
"oi_change": 0,
"type": "put"
}
]
}
}
Data:
{
"vix": 15.28,
"sp500": 7728.2,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.48,
"hy_spread": 2.7,
"treasury": {
"date": "2026-08-12",
"month1": 3.78,
"month2": 3.8,
"month3": 3.87,
"month6": 3.97,
"year1": 4,
"year2": 4.2,
"year3": 4.25,
"year5": 4.38,
"year7": 4.52,
"year10": 4.68,
"year20": 5.24,
"year30": 5.24
},
"events": []
}
Data:
{
"days": 53,
"patterns": [
{
"name": "VWAP Touch",
"count": 53,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 53,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 53,
"pct": 100
},
{
"name": "Woodie Pivot Touch",
"count": 52,
"pct": 98
},
{
"name": "ORB Breakout",
"count": 50,
"pct": 94
},
{
"name": "PDH/PDL Touch",
"count": 45,
"pct": 85
},
{
"name": "Gap Fill",
"count": 42,
"pct": 79
},
{
"name": "Open Retracement",
"count": 31,
"pct": 58
},
{
"name": "High Vol Open",
"count": 13,
"pct": 25
},
{
"name": "Power Hour",
"count": 11,
"pct": 21
},
{
"name": "Darvas Box",
"count": 6,
"pct": 11
}
]
}